Company Profile
Alpine Immune Sciences Stock Price, News & Analysis
- Ticker:
- ALPN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
64.97 USD
Close
Last updated: May 17, 2024 at 00:00
—
Market cap
Why the stock is moving
ALPN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Alpine Immune Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Alpine Immune Sciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Alpine Immune Sciences follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Alpine Immune Sciences sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Alpine Immune Sciences (ALPN)?
Alpine Immune Sciences (ALPN) most recently closed at 64.97 USD.
What does Alpine Immune Sciences do?
Alpine Immune Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ALPN stock listed?
Alpine Immune Sciences (ALPN) is associated with NASDAQ, United States, Biotechnology.
What is Alpine?
Alpine Immune Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Alpine Immune Sciences targeting with Alpine?
Alpine Immune Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Immune?
Alpine Immune Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Sciences?
Alpine Immune Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.